Checchi Capital Advisers, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Checchi Capital Advisers, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$249,423
+9.6%
16,123
+11.3%
0.02%
+15.0%
Q2 2023$227,638
+0.6%
14,490
+5.5%
0.02%
-9.1%
Q1 2023$226,303
+5.3%
13,732
-0.3%
0.02%0.0%
Q4 2022$214,859
+19.4%
13,773
-1.0%
0.02%
+29.4%
Q3 2022$180,000
-8.2%
13,909
+3.7%
0.02%0.0%
Q2 2022$196,000
+5.4%
13,414
+3.4%
0.02%
+6.2%
Q1 2022$186,000
+19.2%
12,967
+13.3%
0.02%
+14.3%
Q4 2021$156,000
-44.1%
11,449
-32.9%
0.01%
-50.0%
Q3 2021$279,000
-2.8%
17,063
+0.2%
0.03%0.0%
Q2 2021$287,000
-9.2%
17,037
-1.6%
0.03%
-9.7%
Q1 2021$316,000
+0.3%
17,322
+0.1%
0.03%
-3.1%
Q4 2020$315,000
-12.0%
17,309
-13.6%
0.03%
-20.0%
Q3 2020$358,000
-3.0%
20,042
-2.6%
0.04%
-9.1%
Q2 2020$369,000
+23.8%
20,579
+4.8%
0.04%
+51.7%
Q1 2020$298,000
-18.1%
19,642
+6.4%
0.03%
-40.8%
Q4 2019$364,000
+46.2%
18,467
+27.6%
0.05%
+53.1%
Q3 2019$249,000
+0.8%
14,477
+3.9%
0.03%
+3.2%
Q2 2019$247,000
-25.4%
13,930
-14.2%
0.03%
-20.5%
Q1 2019$331,00016,2320.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders